KREJČÍ, Marta, Zdeněk ADAM, Andrea KŘIVANOVÁ, Luděk POUR, Lenka ZAHRADOVÁ, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience. ISSN 0390-6078. 2010. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{888195, author = {Krejčí, Marta and Adam, Zdeněk and Křivanová, Andrea and Pour, Luděk and Zahradová, Lenka and Mayer, Jiří and Vorlíček, Jiří and Hájek, Roman}, language = {eng}, title = {Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience}, year = {2010} }
TY - CONF ID - 888195 AU - Krejčí, Marta - Adam, Zdeněk - Křivanová, Andrea - Pour, Luděk - Zahradová, Lenka - Mayer, Jiří - Vorlíček, Jiří - Hájek, Roman PY - 2010 TI - Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience N2 - The thalidomide-based and bortezomib-based regimens are effective in treatment of the first relapse MM with ORR 45-56%. Medians of TTP and OS are similar for both treatment groups, combination of novel agent with other drugs (dexamethason and/or alkylating agent) seems to be very useful. However, the significance part of patients (37-38%) had progression on this treatment and other treatment strategies are needed. ER -
KREJČÍ, Marta, Zdeněk ADAM, Andrea KŘIVANOVÁ, Luděk POUR, Lenka ZAHRADOVÁ, Jiří MAYER, Jiří VORLÍČEK a Roman HÁJEK. \textit{Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience}. ISSN~0390-6078. 2010.
|